Media Releases

12/1/2022, Lexington, KY: Thynk Health and Riverain, pioneers in the healthcare artificial intelligence space, have announced a partnership between their platforms to fight lung cancer with the world’s most advanced technologies. Combining all the latest technologies, including CAD, Machine Learning, clinical NLP, recurrent neural networks, and artificial intelligence, this partnership offers an unprecedented opportunity for lung […]

August 9, 2022, Lexington, KY: Thynk Health is a market-leading platform designed to simplify the management of incidental findings and cancer screening. Seeing exponential growth and continued product innovation, Thynk Health is excited to bring Dr. Shawn Regis to the team as Director of Analytics and Clinical Quality Assurance. “Being involved with lung screening for many

May 16, 2022, Lexington, KY: Thynk Health, the Complete Incidental Findings, and Cancer Screening Management Solution, welcomes Jim Farmer as Senior Vice President of Sales. With over 30 years of experience in executive management and business thought leadership, Jim excels at creating scalable, sustainable growth for early and growth-stage technology-based companies. Utilizing his strengths as

LEXINGTON, Ky., July 12, 2021 – Thynk Health, the Complete Lung Cancer Screening Solution, announced and welcomed Kim Parham as VP of Strategic Partnerships and Clinical Liaison as the company enters into a new wave of growth and business development. Kim began her professional career upon getting her degree at Vanderbilt University and brings with her

May 10, 2021 – Lexington, KY: Thynk Health is transforming cancer screening and incidental findings management with the state-of-the-art Enterprise Incidental Findings Tracker.  In the United States, approximately 1.9 million new cancer cases are expected to be diagnosed in 2021 alone. While healthcare systems offer some of the most advanced treatments for cancer in the

Thynk Health and InferVision Partner to Fight Lung Cancer with Advanced AI and Deep Learning Technologies [02/10/2021], Lexington, KY: Thynk Health and Infervision, pioneers in the healthcare artificial intelligence space, have announced a partnership between their platforms to fight lung cancer with the world’s most advanced technologies. By combining AI-driven data and analytics abstracted from EHRs

MercyOne Des Moines Increases New Patient Lung Cancer Screenings by 76.2% in the First Year [09/24/2020], Lexington, KY: Lung Cancer accounts for 25 percent of cancer-related deaths in the U.S. and causes more deaths than the next three cancers combined. Yet, lung cancer screening rates remain some of the lowest. Empowered by Thynk Health’s complete

Thynk Health to collect and submit the ACR’s new COVID-19 data elements May 27, 2020, Lexington, KY: COVID-19 has created new challenges for lung cancer screening programs, in many cases, delaying screenings by several months and creating more difficulty for administrative and scheduling teams.   Thynk Health’s lung cancer solution tracks all screening follow-up and downstream

January 23, 2020, Lexington, KY: Thynk Health, the Complete Lung Cancer Screening Solution, welcomes Mike Dolan as Senior Vice President of Sales,  where he joins Rob Hamilton in leading sales and marketing initiatives as the company enters into a new wave of growth and business development. Dolan brings more than 30 years of experience across

January 22, 2020, Lexington, KY: Thynk Health, the Complete Lung Cancer Screening Solution, welcomes Michael Young as Senior Vice President of Engineering,  where he will lead innovation and product development. Young brings more than 20 years of healthcare software and medical records development experience. A strong advocate of cutting-edge integration and development platforms, he is